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The a and b Subunits of the Metalloprotease Meprin
Are Expressed in Separate Layers of Human
Epidermis, Revealing Different Functions in
Keratinocyte Proliferation and Differentiation
Christoph Becker-Pauly1, Markus Ho¨wel2, Tatjana Walker2, Annica Vlad3, Karin Aufenvenne2, Vinzenz Oji2,
Daniel Lottaz4, Erwin E. Sterchi4, Mekdes Debela5, Viktor Magdolen6, Heiko Traupe2 and Walter Sto¨cker1
The zinc endopeptidase meprin (EC 3.4.24.18) is expressed in brush border membranes of intestine and kidney
tubules, intestinal leukocytes, and certain cancer cells, suggesting a role in epithelial differentiation and cell
migration. Here we show by RT-PCR and immunoblotting that meprin is also expressed in human skin. As
visualized by immunohistochemistry, the two meprin subunits are localized in separate cell layers of the human
epidermis. Meprin a is expressed in the stratum basale, whereas meprin b is found in cells of the stratum
granulosum just beneath the stratum corneum. In hyperproliferative epidermis such as in psoriasis vulgaris,
meprin a showed a marked shift of expression from the basal to the uppermost layers of the epidermis. The
expression patterns suggest distinct functions for the two subunits in skin. This assumption is supported by
diverse effects of recombinant meprin a and b on human adult low-calcium high-temperature keratinocytes.
Here, b induced a dramatic change in cell morphology and reduced the cell number, indicating a function in
terminal differentiation, whereas meprin a did not affect cell viability, and may play a role in basal keratinocyte
proliferation.
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INTRODUCTION
Meprin (EC 3.4.24.18) is a zinc endopeptidase of the astacin
family and the metzincin superfamily, originally found in
intestinal and renal brush border membranes of humans,
mice, and rats (Sterchi et al., 1982, 1983, 1988). Meprins
consist of two homologous subunits, a and b, which assemble
to homo- or heterooligomeric complexes, whose basic unit is
a disulfide-linked dimer (Becker et al., 2003; Bertenshaw
et al., 2003; Ishmael et al., 2005). Both subunits are
multidomain type 1 membrane proteins composed of an
amino-terminal propeptide, an astacin-like protease domain
with the extended zinc binding active site motif
HEXXHXXGFXHE and a conserved methionine residue in a
b-1,4-turn (Met-turn) (Sto¨cker et al., 1993, 1995; Bond and
Beynon, 1995), a MAM domain (meprin A5 protein tyrosine
phosphatase m), and a TRAF domain (tumor necrosis factor
receptor associated factor), which are thought to mediate
protein–protein interactions, followed by an epidermal growth
factor-like module, the C-terminal transmembrane domain,
and a cytosolic tail. An inserted (I) domain in the a subunit is
cleaved on the secretory pathway, resulting in the loss of the
membrane anchor and subsequently in the secretion of the
enzyme in those tissues, where a is not co-expressed with b,
whereas the b subunit predominantly remains membrane
bound (Marchand et al., 1995; Eldering et al., 1997). In
contrast to the rodent orthologs, the human meprin b subunit
contains several O-glycosylation sites in the extracellular part
near the membrane. Human meprin oligomers may be shed
from the cell surface by proteolytic cleavage in this region
(Hahn et al., 2003; Leuenberger et al., 2003). Activation of
meprins requires the removal of the N-terminal pro-peptide,
and is catalyzed by trypsin in the intestinal lumen. Plasmin
has also been identified as a meprin a activating enzyme
(Ro¨smann et al., 2002). However, this does not apply to
promeprin b, whose activation site appears to be inaccessible
for peptidases larger than trypsin (Becker et al., 2003).
There are various in vitro observations of a cleavage of
basement membrane proteins (e.g., collagen IV, nidogen-1,
and fibronectin), protein kinases, growth factors, cytokines
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(interleukin-1b), and other bioactive peptides by meprin, but
both subunits exhibit markedly different cleavage specificities
(Choudry and Kenny, 1991; Kaushal et al., 1994; Chestukhin
et al., 1997; Ko¨hler et al., 2000; Bertenshaw et al., 2001;
Kruse et al., 2004; Herzog et al., 2005).
Meanwhile, a broader range of sites of meprin expression
other than kidney and intestine has been discovered, which
varies between species and between developmental stages
within a species. The subunits may be co-expressed or
expressed individually as shown for the human intestine,
where meprin b is expressed in the small intestine only, but
meprin a is expressed in both the small and large intestine
(Lottaz et al., 1999a). Contrarily, in newborn mice, a more
ubiquitous distribution of meprin subunits in the intestine and
kidney has been reported (Kumar and Bond, 2001). However,
after weaning the mRNA of meprin a was barely detectable in
the intestine of ICR and C3H/He mice (Kumar and Bond,
2001). Less described expression sites of meprin are the
salivary glands of mice (Craig et al., 1991), the plexus
choroideus, the inner ear, the nasal epithelium, and smooth
muscle cells of rats (Bunnett et al., 1993; Spencer-Dene et al.,
1994). In humans, meprin mRNA was also detected in the
liver, skeletal muscle, stomach, and pancreas (http://merops.
sanger.ac.uk). The observation that intestinal leukocytes
express meprin (Lottaz et al., 1999a) suggests a function in
innate immunity. This assumption is supported by the
analysis of meprin/ mice (Crisman et al., 2004), in which
these lymphoid cells exhibited a restricted ability to migrate
through the extracellular matrix.
Additionally, meprin has also been detected in certain
epithelial carcinomas such as colorectal cancer (Matters and
Bond, 1999; Lottaz et al., 1999b), where soluble human
meprin a is secreted not only apically but also basolaterally,
thereby increasing the proteolytic potential of tumor cells for
the destruction of the basement membrane (Kruse et al.,
2004). An abnormal meprin secretion has also been observed
in rats with experimentally induced acute renal failure
(Trachtman et al., 1995; Carmago et al., 2002). Taken
together, these findings suggest a contribution of meprin to
epithelial differentiation, matrix remodelling and cell migra-
tion, and also to inflammatory processes, tumor growth and
metastasis.
Much less is known on alternative sites of meprin
expression in adult mammalian tissues besides the tissues
mentioned above. Here we present human skin as a new
expression locus of meprin a and b. The fact that each subunit
is expressed in a distinct cell layer of the epidermis, namely
the stratum basale and the stratum granulosum, demonstrates
the uniqueness of these proteases and reveals different
physiological functions.
RESULTS
The antisera used for meprin detection are subunit specific and
allow for a clear distinction between meprin a and b
To examine the specificity of the polyclonal antibodies used
for the immunofluorescences, we tested meprin expressing
insect cells (Sf9, Spodoptera frugiperda). These cells were
infected with Baculo viruses containing human meprin a or b
cDNA as described before (Becker et al., 2003). Non-infected
cells were used as a control for unspecific signals. Meprin a
and b-expressing cells were detected by the a and b antisera,
respectively (Figure 1). Furthermore, an antiserum directed
against both subunits provided signals in both transfected cell
lines. These results comply with the specificity of the antisera
observed in the Western blot analysis (Figure 2j). Not all
insect cells show fluorescence signals, which is because not
all host cells are infected simultaneously resulting in different
meprin levels. However, the selectivity of the antibodies used
for the different meprin subunits is clearly evident. To
exclude the fact that the antisera bind non-specifically in
human tissues, cryosections from human ileum were
analyzed. Fluorescence signals could be detected only on
the apical side of the intestinal epithelium and on certain
cells in the lamina propria, corresponding to leukocytes (data
not shown), which is in accordance with published data
(Lottaz et al., 1999a).
Both meprin subunits are detected in human epidermal skin,
albeit in different cell layers
The antisera were then used to analyze cryosections of
human skin for meprin expression (Figure 2a and b). The
fluorescence signals obtained by the a-specific antiserum
localize exclusively to keratinocytes of the stratum basale
(Figure 2a), the epidermal cell layer, where cell proliferation
occurs. The signals appear strictly perinuclear. No fluores-
cence is observed at the cell membranes or in the
extracellular space. By contrast, the data obtained for meprin
b show an expression pattern restricted to the stratum
granulosum displaying a linear pericellular staining of 3–4
cell layers (Figure 2b). Hence, both meprin subunits are
expressed in the epidermis, but they are strictly separated,
which confirms their different functionality. To prove further
specificity of the antisera, recombinant meprin a and b were
preincubated with the used antisera, which resulted in the
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Figure 1. Control assay to test the specificity of the used antisera. Meprin
transfected and nontransfected insect cells (Spodoptera frugiperda, Sf9) were
incubated with antibodies (Abs) generated against meprin a, b, and both
subunits. Bar¼ 50mm.
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absence of meprin-specific fluorescence signals (Figure 2c
and d). Moreover, the antiserum recognizing both sub-
units resulted in fluorescence signals in both the stratum
basale and the stratum granulosum (Figure 2e). Meprins could
also be detected in hair follicles. The signal for meprin b is
present in the region of the inner root sheath, whereas
meprin a is localized in the outer root sheath (Figure 2f
and g).
Western blot analysis demonstrated the presence of both
meprin subunits in cell lysates of healthy human skin as well
as in extracts of human hair roots (Figure 2j, lanes 1–4). Under
reducing conditions the crossreactive a/b antiserum stained
two bands (Figure 2j, lane 1), in the range of about 90 and
110 kDa, corresponding to meprin a and b, respectively. The
same lysate analyzed with the b-specific antiserum revealed
only the band of the higher molecular weight (Figure 2j, lane
2), indicative of meprin b, which is C-terminally elongated in
comparison to the a subunit. Under non-reducing conditions
a strong band of about 220 kDa is visible corresponding to
disulfide-linked dimers (Figure 2j, lanes 3,4). The detection of
more protein in the range of 110 kDa is probably due to still
unsecreted and unprocessed promeprin a.
Human keratinocytes express meprin a and b
The expression patterns of meprin in human skin keratino-
cytes could be confirmed in human adult low-calcium high-
temperature (HaCaT) cells. In these cell cultures, meprin a is
expressed at the borderline of proliferating cell clusters
(Figure 2h), whereas the b subunit was detected only after
total confluence was achieved, in cells that have most

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Figure 2. Distribution of meprin a and b in human skin and HaCaT cells. (a, b) Immunofluorescences of normal skin for meprin a and b, respectively. (c, d) As a
control, recombinant antigen was competitively incubated with the antisera, resulting in vanished fluorescence signals. Using the antiserum recognizing both
meprin a and b, the signals appear in both cell layers of the epidermis (e), corresponding to the results for each subunit alone (a, b). In cross-sections of hair
follicles, meprin a (f) could be detected in the outer root sheath, whereas the b subunit (g) is expressed by cells in the inner root sheath. Confocal fluorescence
reveals that meprin a (h) predominantly occurs at the border of non-confluent cell areas, where the HaCaT cells still proliferate. In contrast, meprin b (i) is
expressed by confluent cells that are more differentiated. Dotted lines show the relative positions of the basement membrane; straight lines denote the outermost
layers of the skin. Asterisks indicate the position of the hair. Arrows point out fluorescence signals. Nuclei of HaCaT cells are marked by 4,6-diamidino-2-
phenylindole (h, i). Bar¼ 50mm. To detect meprin subunits by Western blot analysis (j) lysates from skin biopsies, hair roots, and HaCaT cells were run on SDS-
PAGE (7.5%) with or without DTT, and transferred to polyvinylidene fluoride membrane. Blots were probed with rabbit anti-human meprin a/b (lanes 1,3,5,7)
and meprin b antisera (lanes 2, 4, 6, 8). Signals could be measured due to HRP-coupled secondary antibodies.
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probably reached a later stage of differentiation (Figure 2i).
This could be confirmed using HaCaT cells, which were
treated with different Ca2þ concentrations, thereby triggering
the differentiation of these cells. At low Ca2þ levels
(0.03 mM), merely the expression of meprin a could be
observed by immunofluorescence microscopy whereas the b
subunit was detectable only at higher Ca2þ levels (1.0 and
1.5 mM) (Figure 3a). Under these conditions, we also
observed the expression of transglutaminase 1, a marker of
keratinocyte differentiation (Sayama et al., 2001) (Figure 3a).
These findings are in correlation to the mRNA expression
of meprins in HaCaT cells (Figure 3b, lanes 1, 2, 4, 5). The
mRNA of the a subunit is detectable in freshly disseminated
cells (Figure 3b, lane 1), whereas meprin b mRNA appears
only upon complete confluence of keratinocytes (Figure 3b,
lanes 4,5). Additionally, the results obtained by immuno-
fluorescence analysis were supported by Western blots
(Figure 2j, lanes 5–8), which detected meprin a and b, albeit
in lower concentrations as compared to the protein isolated
from hair roots.
Recombinant meprin b, but not a, changes the shape and
reduces the number of HaCaT cells
In order to investigate whether meprin a or b has an influence
on cell growth and proliferation, we added recombinant
protein in different concentrations to confluent grown HaCaT
cells. Incubation with recombinant meprin a, as active
enzyme or zymogen form, did not show any obvious
influence on the keratinocytes even at high concentrations
(Figure 4a and b). By contrast, incubation with active meprin
b caused dramatic changes in cell number and morphology
(Figure 4d–h). Increasing the meprin b concentration led to an
increase of cell-free areas and to an altered cell shape. After
18 hours incubation, the remaining keratinocytes had a
stretched and flattened appearance and gathered to form
strands of only a few cell layers thickness (Figure 4h and i).
Incubation of HaCaT cells with promeprin b did not show
morphological effects except at the highest concentration
(10 mg/ml) (Figure 4c); this may indicate that the zymogen
form can be activated by secreted proteases from the HaCaT
cells. Furthermore, the addition of actinonin, an inhibitor of
both meprin subunits (Kruse et al., 2004), to meprin b-treated
cells revealed normally grown keratinocytes (Figure 4j).
The viability of the cells after treatment with recombinant
meprins was tested in a proliferation assay (Figure 5a). As
assumed, only meprin b had a significant influence on cell
number. An increase in the concentration of active protein up
to 10 mg/ml leads to a decrease of the total cell number down
to 10%. Promeprin b reduced the cell number to about 30%.
To verify whether this effect on cell viability was due to
general cytotoxicity or a more regulated process, an assay
was performed testing the binding capacity of annexin V to
phosphatidylserine, which is typical for the initial phase of
apoptosis. As visualized by immunofluorescence micro-
scopy, incubation with 5 mg/ml active meprin b resulted in
increased apoptosis at the border of newly originated cell-
free areas (Figure 5d), whereas in confluent areas the cells
appeared almost identical to untreated keratinocytes (Figure
5b and c).
Human kallikrein-related peptidase 4 (KLK4) is a potent
activator for meprin b
Owing to the lack of pancreatic trypsin outside the gut, we
searched for an alternative activator of promeprin b in the
skin. In contrast to promeprin a, which can be activated by
plasmin outside the intestine (Ro¨smann et al., 2002), this is
not the case for promeprin b owing to sterical reasons (Becker
et al., 2003). Therefore, we tested whether kallikrein-related
peptidases (Debela et al., 2006b), which are expressed in the
skin (Komatsu et al., 2003), are able to activate promeprin b
in vitro. In the course of these experiments we found that
KLK4 was able to transform the zymogen of meprin b to its
mature form within the same efficiency as pancreatic trypsin,
visualized by an activity assay using azocasein as substrate
(Figure 6a). Promeprin bwas activated with trypsin or KLK4 at
371C for different periods of time. Although 100 nM trypsin
fully activated the b subunit within 30 minutes, incubation
with 300 nM KLK4 generated maximum meprin b activity
within 120 minutes. Azocasein degrading activity could be
a
b
Ca2+: 0.03 mM
50%
c
321
100%
Cell
confluency
0.5 mM 1.0 mM 1.5 mM
TGase1
Ab
 Ab
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 c
654
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Figure 3. Meprin expression depends on the differentiation level of
keratinocytes. (a) HaCaT cells were cultured in media containing different
Ca2þ concentrations (0.03, 0.5, 1.0, and 1.5 mM; from left to right). To
evaluate the stage of keratinocyte differentiation, a transglutaminase 1
antibody (TGase1 Ab) was used (green fluorescence). Meprin a and b
expression could be detected by subunit-specific antisera a Ab and b Ab,
respectively (red signals). Cell nuclei are marked by 4,6-diamidino-2-
phenylindole. Bar¼ 50mm. To determine meprins on mRNA level in
proliferating and more differentiated keratinocytes (b), total RNA was isolated
from HaCaT cells and transcribed into cDNA by RT-PCR using oligo(dT)
primers. Meprin a (lanes 1,4) and b (lanes 2,5)-specific primers were used for
PCR, as well as b-actin (lanes 3,6) for control (c). Samples were loaded on an
agarose gel (1%) and visualized by ethidium bromide.
1118 Journal of Investigative Dermatology (2007), Volume 127
C Becker-Pauly et al.
Expression of Human Meprin in Skin
completely inhibited by adding 0.1 mM actinonin (data not
shown). These results were verified on the protein level by
Western blot analysis (Figure 6b). Incubation of promeprin b
with 300 nM KLK4 (Figure 6b, lanes 2–7) and subsequent
immunoblotting with different antibodies revealed protein
bands corresponding to the zymogen (z) and mature (m)
forms of human meprin b. A meprin b-specific antibody (b
Ab) recognizing the zymogen and mature forms and an anti-
His-tag antibody (His Ab) were used in the upper and lower
panel, respectively. It is obvious that human promeprin b is
almost completely converted to its active form by limited
KLK4 digestion within 90 minutes, as indicated by the
bandshift due to the conversion of the zymogen to the
mature enzyme (Figure 6b, lanes 2–7, upper panel). The
newly generated band shows the same electrophoretic
mobility as trypsin-activated meprin (Figure 6b, lane 8, upper
panel). As a control, untreated promeprin b was loaded on
lane 1. During activation, the propeptide of recombinant
promeprin b including the N-terminal His-tag is cleaved. This
correlates to the vanishing signal observed with the His Ab.
The signal for promeprin b disappears upon prolonged
incubation with KLK4 (Figure 6b, lanes 2–7, lower panel).
a b
c d
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g h
i j
Figure 4. Influence of recombinant meprin on HaCaT cells. After total
confluence was achieved, recombinant promeprin a (a) and b (c), as well as
their active forms (b and d–h, respectively) were added to the keratinocytes in
concentrations of 0.1mg/ml (d), 1mg/ml (e), 2mg/ml (f), 5mg/ml (g), and 10mg/ml
(a–c, h) followed by incubation in a humidified chamber for 18 hours at
371C. To visualize the change in cell shape, a typical area is shown at a
greater magnification (i). The black arrow indicates normally growing
roundish HaCaT cells; the white arrow points out keratinocytes, which have a
stretched and narrower shape. The inhibitor actinonin (0.5 mM) was added to
meprin b (10mg/ml) incubated keratinocytes (j) in order to verify that catalytic
activity is responsible for the change of cell morphology. Arrows indicate
cell-free areas. Bars¼ 50 mm.
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Figure 5. Influence of recombinant meprins on the proliferation of
keratinocytes. (a) HaCaT cells were incubated with recombinant meprins in
the following concentrations: 0.1, 0.5, 1, 2, 3, 5, and 10 mg/ml. To obtain
100% cell viability, an untreated control was analyzed. The percentage of
living keratinocytes was quantified using MTT as a substrate for the
gluthathione-S-transferase (Invitrogen, Karlsruhe, Germany). The diagram
shows the results of threefold assays. To test whether the decreased cell
number is due to cytotoxic or apoptotic effects caused by meprin b, an
Apoptosis Detection Kit II (Calbiochem/Merck, Darmstadt, Germany) was
used. Untreated HaCaTs (b) exhibit constitutive apoptotic signals in the same
way as meprin b (5 mg/ml)-treated keratinocytes in confluent areas (c). Only at
the border of cell-free areas (encircled by dotted lines) a strong increase of
apoptosis was detected (d). White arrows indicate non-apoptotic cells.
Bar¼50 mm.
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Again, this is in agreement with trypsin-activated meprin
(lane 8).
The expression pattern of human meprin changes drastically
during hyperproliferative hyperkeratosis
To further assess meprin expression, different skin diseases/
keratinization disorders were studied: skins from four patients
with Netherton syndrome (N.s.), five patients with psoriasis
vulgaris (P.v.), and five patients suffering from ichthyosis
vulgaris (I.v.) (Figure 7). In I.v. – a model disease for a
retention hyperkeratosis, characterized by hypoproliferative
epidermis – the expression of meprin a was rather strong, but
the distribution of the enzyme was comparable to healthy
skin. By contrast, in skin diseases characterized by epidermal
hyperproliferation such as Netherton Syndrome and psoriasis,
the a subunit was dislocated and expressed in the uppermost
layers of the epidermis corresponding to the stratum
granulosum. Furthermore, as far as meprin b is concerned,
we observed that its expression is no longer restricted to the
stratum granulosum, but can also be found in the stratum
corneum.
DISCUSSION
With regard to the described expression sites of meprin, the
question arose as to whether this enzyme is also present in
human skin, the largest epithelial organ. In fact, here we
show by immunofluorescence studies that both meprin
subunits are constitutively expressed in normal human
epidermis, but not detectable under the same assay condi-
tions in the underlying dermis and subcutis. The epidermis is
a constantly proliferating tissue and makes up about 3% of
the total skin; it comprises several cell layers piling up to a
thickness between 0.02 and 1 mm (Jastrow and Vollrath,
2002). The most amazing and concurrently the most
interesting point is that the two meprin subunits are not
colocalized. The a subunit is expressed exclusively in the
keratinocytes of the basal layer, the stratum basale, where
cell division and proliferation occur. By contrast, meprin b
could only be identified in the cells of the stratum
granulosum, that layer of the epidermis where the cornified
envelope is formed and the epidermal barrier is established
(Candi et al., 2005).
Meprin a immunofluorescence in the basal layer is mostly
perinuclear, whereas meprin b staining is restricted to the cell
borders. This subcellular distribution of the two subunits is
consistent with their different processing along the secretory
pathway. If expressed alone, meprin a is secreted, because it
loses its membrane anchor owing to proteolytic cleavage
within the I-domain (Marchand et al., 1995; Tang and Bond,
1998). Outside the stratum basale secreted meprin a is
diluted by diffusion and therefore escapes detection. This
observation is comparable to results from other groups also
working with secreted proteases in human skin (Sadowski
et al., 2003; Buth et al., 2004). On the other hand, meprin b-
producing cells of the stratum granulosum integrate the
enzyme within their plasma membrane, because b does not
contain a cleavable I-domain and therefore remains pre-
dominantly membrane bound (Butler et al., 1987; Hahn
et al., 2003). The localization of meprin b limits its activity to
the narrow pericellular space.
The observation that both meprin subunits are expressed
in different cell layers, implying different roles for keratino-
cyte differentiation, could be confirmed using HaCaT cells.
 Ab
 Ab
I.v. N.s. P.v.
Figure 7. Meprin expression in hyperkeratotic and hyperproliferative skins.
Meprin expression (a Ab and b Ab) in pathological situations was analyzed
taking skins from patients with N.s. and patients with P.v. as examples of
hyperproliferation disorders and from I.v. Although, the expression pattern of
meprin in hypoproliferative epidermis (I.v.) was comparable to healthy skin
(Figure 2a and b), the situation dramatically changed in hyperproliferative
epidermis. Here, the a subunit is relocated and appears at the S. granulosum
area (N.s. and P.v.). Dotted lines show the relative positions of the basement
membrane; straight lines denote the outermost layers of the skin. Smaller
pictures give an overview of the entire epidermis. Bar: 50 mm.
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Figure 6. Promeprin b is activated by human kallikrein-related peptidase 4.
(a) Recombinant promeprin b was activated using 100 nM trypsin (black) or
300 nM KLK4 (white) at 371C for given periods of time and later tested for
azocasein cleaving activity. After preincubation, trypsin and KLK4 were
inhibited by the addition of 5 mM Pefabloc. The data represent averages of two
independent activity assays (þ / maximum/minimum). Absorbance at
340 nm correlates to proteolytic activity. To visualize the proteolytic cleavage
of the zymogen during activation, promeprin b was activated with 300 nM
KLK4 at 371C for 1, 15, 30, 60, 90, and 120 minutes (b, lanes 2–7) and aliquots
were subjected to SDS electrophoresis and immunoblotting. An antibody (b
Ab) detecting the zymogen (z) and the mature (m) form of meprin b was
applied in the upper panel, and an anti-His-tag antibody (His Ab) detecting
only the zymogen was used in the lower panel. As controls the untreated
zymogen (lane 1) and trypsin-activated meprin b (lane 8) were loaded.
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When these keratinocytes were cultured in a medium
containing low Ca2þ concentrations (0.03 mM), they main-
tained a proliferative basal cell-like phenotype. By elevating
the Ca2þ concentration to above 0.1 mM, the cells can be
induced to differentiate in vitro (Watt and Green, 1982).
Further elevation of Ca2þ concentrations to 1.0 mM or higher
induces terminal differentiation and cornification. This
differentiation process closely follows the maturation pattern
of epidermis in vivo (Yuspa et al., 1989). We could show that
meprin expression in keratinocytes depends on the particular
stage of cell differentiation; hence, the a subunit could be
detected in keratinocytes treated with low Ca2þ concentra-
tions (0.03 mM), whereas meprin b is expressed by HaCaT
cells, which are cultured under high Ca2þ levels (1.5 mM).
From the proliferation of keratinocytes in the stratum
basale to their cornification in the stratum corneum, the cells
are passing through several stages of differentiation (Eckert
et al., 1997). The meprin a expressing stratum basale consists
of cylindrical keratinocytes with relatively large nuclei,
which are separated from the dermis by a basement
membrane. In contrast, meprin b expression occurs in the
stratum granulosum, the cell layer where keratinocytes
undergo a most dramatic change in their morphology and
physiology, resulting in cell flattening and loss of the nuclei.
Thus, meprin subunits are involved in completely different
physiological processes, with a and b being expressed by
keratinocytes in their initial and terminal stages of differ-
entiation, respectively. So far there are no data about the
downregulation of meprin expression or about the half life of
meprin on the protein level. Meprins are not inhibited by the
tissue inhibitors of metalloproteases or a2-macroglobulin.
The presumed functional difference between the two
meprin subunits could be visualized in the present work by
their influence on cultured human keratinocytes (HaCaT
cells). Confluently grown HaCaT cells were obviously not
affected by either the zymogen or the active form of meprin a,
whereas active meprin b led to a dramatic change in cell
number and morphology. This effect on keratinocytes is
promoted by the catalytic activity of the b subunit, because
the addition of actinonin, a potent inhibitor for meprin,
resulted in a behavior comparable to untreated cells.
Interestingly, there was also a small but significant decrease
in cell number upon addition of inactive promeprin b. We
assume that this might be due to zymogen activation by an
endogenous protease. The possible mode of activation is
discussed below. Concomitant with the decrease in cell
numbers, there was a change in cell morphology from round
to stretched/flattened cells that exhibit a tendency to form
stacks as seen in the cells of the stratum corneum. This
suggests that meprin b might be involved in the terminal
differentiation of keratinocytes at the junction between the
stratum granulosum and the stratum corneum. Moreover, we
could show that meprin b-treated cells reacted positively in
an assay for the initial phase of apoptosis. This was almost
exclusively seen in keratinocytes at the borders of cell-free
areas. Terminal epidermal differentiation is associated with
cell death in the skin and therefore somewhat resembles
apoptosis (Candi et al., 2005). On the other hand, there is
evidence that cornified cell envelope formation is distinct
from apoptosis in epidermal keratinocytes (Takahashi et al.,
2000). Therefore, the issue of a role for meprin b in
differentiation processes of human keratinocytes remains
intriguing and deserves further attention.
An earlier report by Carmago et al. (2002) demonstrated
that meprin A (a designation for a mixture of meprin a
homooligomers and a/b heterooligomers) has a negative
effect on the viability of certain strains of kidney cells (LLC-
PK1, immortalized porcine epithelial cells; MDCK, Madin-
Darby canine kidney cells). In the light of our data acquired
with homogeneous a and b subunits, it appears most likely
that meprin b was responsible for the decrease in cell
number, once more indicating that this metalloprotease is
capable of inducing epithelial cell differentiation.
By contrast, it is tempting to speculate that meprin a might
be involved in the detachment of basal keratinocytes from the
basement membrane found beneath the stratum basale in the
initial phase of keratinocyte differentiation. This view is
consistent with the observation of a possible role of meprin a
in certain pathological situations like colorectal cancer,
where it has been suggested to be important for the migration
of transformed epithelial cells through the basement mem-
brane (Lottaz et al., 1999b). Meprin a is capable of cleaving
major components of the basement membrane like collagen
IV, nidogen 1, laminin V, and fibronectin (Kruse et al., 2004).
In abrasively growing melanoma cells, the degradation of the
extracellular matrix is triggered by plasmin, which is
activated from its precursor plasminogen by urokinase (Quax
et al., 1991a, b; de Vries et al., 1994). We have shown
previously that the urokinase/plasminogen system is also an
activator for human promeprin a (Ro¨smann et al., 2002;
Becker et al., 2003). Therefore, it is conceivable that meprin
is implicated in the pathogenesis of melanoma formation
and/or progression. The a subunit could also be involved in
wound healing processes as it is described for MMP-19
(Sadowski et al., 2003). This metalloprotease is expressed in
basal undifferentiated cells of the epidermis and regulates
insulin-like growth factor-mediated proliferation, migration,
and adhesion in keratinocytes through proteolysis of insulin-
like growth factor binding protein-3.
Additionally, we could show that meprin a is relocated in
skin diseases characterized by epidermal hyperproliferation,
namely in psoriasis vulgaris and in Netherton syndrome.
Here, the basal keratinocytes show an increased mitotic
activity, resulting in a thickened epidermis. Surprisingly,
meprin a expression is decreased in the stratum basale, but
instead is increased in the uppermost layers of the epidermis,
showing a dotted pericellular signal. This suggests that the
enzyme formed heterooligomers with the b subunit, resulting
in membrane-bound protein, as has been described for the
kidney and small intestine (Gorbea et al., 1991; Lottaz et al.,
1999a). The altered expression pattern of meprin a in
hyperproliferative skin diseases such as psoriasis or Netherton
syndrome suggests that meprin a is involved in the normal
regulation of keratinocyte proliferation.
The different functions of meprin a and b subunits in the
skin are reflected by their different location, and could be due
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to their strikingly different substrate specificities (Bertenshaw
et al., 2003; Kruse et al., 2004) as well as to their modes of
zymogen activation, as only a but not b subunits are activated
by plasmin (Ro¨smann et al., 2002; Becker et al., 2003). A
potent activator for meprin b outside the gut has not been
identified so far. Potential candidates are serine proteases
with trypsin-like specificity, which are colocalized in the
epidermis. Several enzymes such as human kallikrein-related
peptidase 7, HMW-uPa, and tryptases (a1 and b3) (kindly
provided by L. Bruckner-Tudermann, Freiburg, Germany and
C. Sommerhoff, Munich, Germany) failed to activate human
meprin b in vitro. Presumably, these enzymes are too large to
access the cryptic site of activation. Therefore, smaller
members of the serine protease family, such as kallikrein-
related peptidases (Lundwall et al., 2006), are more likely
candidates as activators of promeprin b (Yousef and
Diamandis, 2001; Michael et al., 2005). Here, we could
identify human kallikrein-related peptidase 4 (KLK4) as a
potent activator for the zymogen of the b subunit. Human
kallikrein-related peptidase 4, also known as prostase, is also
expressed by cells of the stratum granulosum (Komatsu et al.,
2003) and therefore it may represent a physiological relevant
regulator of meprin b activity in the skin. Active recombinant
KLK4 has a molecular mass of about 24 kDa (Debela et al.,
2006a, b). At first glance, the enzyme exhibits tryptic
cleavage specificity, but it is more selective in preferring
Arg over Lys in the P1 position and also prefers hydrophobic
residues in the region between P4 and P2 (Takayama et al.,
2001; Matsumura et al., 2005; Debela et al., 2006a, b).
Therefore, KLK4 may be involved in a regulatory network
rather than in degrading processes.
On activation, meprin b may be involved in the
reconstruction of cell–cell contacts at the transition to the
stratum granulosum/stratum corneum interface.
Thus, the discovery of the skin as a meprin-expressing
tissue opens up a new research field, which offers the
possibility to clarify a new intriguing physiological function
of the zinc endopeptidase meprin.
MATERIALS AND METHODS
Patients
The study was approved by the Institutional Review Board of the
University Hospital of Mu¨nster. The Declaration of Helsinki
Principles were followed and all patients enrolled gave their written,
informed consent.
Chemicals, enzymes
All chemicals were of analytical grade and, if not stated otherwise,
obtained from Amersham Bioscience, Freiburg; Applichem, Darm-
stadt; Serva, Heidelberg; Biorad, Munich; Bachem, Heidelberg;
Sigma/Aldrich, Deisenhofen; and Merck, Darmstadt, Germany.
RNA isolation and RT-PCR
All materials were obtained from Peqlab Biotechnology GmbH,
Erlangen, Germany, if not stated otherwise. Total cellular RNA from
HaCaT cells was extracted using the E.Z.N.A. Total RNA Kit
following the manufacturer’s instructions. RNA was then reverse
transcribed to cDNA with M-MuLV reverse transcriptase and used as
a template in PCR. RT-PCR was performed with oligo d(T)16 primers
(ROTH, Karlsruhe, Germany), RNAse inhibitor, dNTPs, and DEPC
water. In each reaction 3 mg of total RNA was used. For PCR, each
incubation mixture was split into three and transferred to new
reaction tubes to amplify meprin a, meprin b, and b-actin separately.
A negative control without reverse transcriptase was run for each
sample of RNA. In addition, a negative control without RNA was run
in parallel with the test samples. The following meprin primers were
synthesized:
meprin a: sense 50-GATGATGACCACAATTGGAAAATTG C-30
antisense 50-ACCTGTCTGTTTTCTACCGGCCACTC-30
meprin b: sense 50-AGAGAGCACAATTTTAACACCTATAGT-30
antisense 50-CTATCGAAATGCATGAAGAAACCAGA-30
b-actin: sense 50-GACATCCGCAAAGACCTGTACG-30
antisense 50-ACTGGGCCATTCTCCTTAGAG-30
PCR was performed for 40 cycles (denaturing at 951C for
45 seconds, annealing at 551C for 30 seconds, extension at 721C
for 60 seconds). PCR products were resolved on 1% agarose gels,
followed by staining with ethidium bromide and recording with a
digital camera. For sequencing, PCR samples were purified by the
E.Z.N.A Cycle-Pure Kit and analyzed at Genterprise (Mainz,
Germany).
Cell lysates and Western blot analysis
Frozen tissue biopsies of 10 normal human skin samples were
homogenized in a mortar. Twenty scalp hairs were each plucked
from ten healthy voluntary individuals and hair roots were
transferred into 40 ml lysis buffer. The samples were kept at 41C for
20 minutes, heated at 991C for 10 minutes, and then stored at 201C
before Western blot analysis.
The homogenate, as well as hair roots or HaCaT cells, was
dissolved in lysis buffer (9.2 mM Na2HPO4, 1.8 mM KH2PO4, 135 mM
NaCl, 2.7 mM KCl, pH 7.4; containing 1% Triton X-100, 1 mM
pepstatin, 1mM E64, 2 mM pefabloc). For immunoblot analysis
proteins were subjected to 7.5% SDS-PAGE (Laemmli, 1970) under
reducing and non-reducing conditions and afterwards transferred
onto a polyvinylidene fluoride membrane (Immobilon P, Millipore,
Eschborn, Germany) by electroblotting (80 mA, 75 minutes). For
detection with meprin-specific antibodies the membrane was
saturated with 5% dry milk in Tris-buffered saline for 1 hour at
room temperature, incubated with the first antibody (polyclonal anti-
meprin a or b antibodies, 1:1,000) for 1 hour and afterwards with
horseradish peroxidase-conjugated anti-rabbit IgG (1:10,000) for
45 minutes at room temperature. Detection was performed using
Rotilumin (ROTH, Karlsruhe, Germany) following the manufac-
turer’s instructions using X-ray film (Hyperfilm ECL, Amersham
Pharmacia Biotech, Freiburg, Germany).
6His-tag marked recombinant promeprin b before and after
KLK4 incubation was visualized using Penta-His antibodies (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions.
Cells and culture conditions
The HaCaT keratinocyte cells were maintained at 371C in a
humidified atmosphere of 5% CO2 (in air) in DMEM (Invitrogen
GmbH, Karlsruhe, Germany) supplemented with 10% fetal bovine
serum and 50 U/ml penicillin and 50 mg/ml streptomycin. For some
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experiments, HaCaT cells were grown in a serum-free DMEM to
avoid inhibitory effects on the used proteases.
Ca2þ switch experiments were performed to study keratinocyte
differentiation. For this purpose, HaCaT cells were cultured in Ca2þ
free DMEM supplemented with 10% fetal bovine serum and 100 U/
ml penicillin/streptomycin at 371C and in 5% CO2. After 1 day, post-
confluence medium was changed to DMEM basal medium (without
growth factors) with 0.03, 0.5, 1.0, and 1.5 mM Ca2þ (500ml per
well). Cells were exposed to experimental medium for 24 hours
followed by another 48 hours of identical medium. The total
experimental period was 96 hours.
Expression and purification of recombinant meprins
Expression, purification, and activation of recombinant meprin b
were performed as described before (Becker et al., 2003). For affinity
purification of recombinant meprin a, a Strep-tag was inserted into
human meprin a-cDNA (Ko¨hler et al., 2000) between signal and
propeptide. The following primers were used:
sense1: 50-GGCGGCCTTGCTGTTCTTCTA-30
antisense1: 50-GAGAGAATTCCTTTTCGAACTGCGGGTGT
GACCACGGTACAGCTGCTATGTGGGCAAAAA-30
sense2: 50-GAG AGA ATT CAT TAA GCA TCT TCC TGAA
GA-30
antisense2: 50-TGG CCT TAT AGG CAC ATC CTT-30
Primers were synthesized by ROTH (Karlsruhe, Germany).
Sequences of constructs were verified by DNA sequencing
(Genterprise, Mainz, Germany). Recombinant protein was expressed
using the Bac-to-Bac expression system (Gibco Life Technologies,
Paisley, UK) following the manufacturer’s instructions. All media
and supplements were obtained from Gibco Life Technologies.
Recombinant baculoviruses were amplified in adherently growing
Spodoptera frugiperda (Sf)9 insect cells at 271C in Grace’s insect
medium supplemented with 10% fetal bovine serum, 50 U/ml
penicillin, and 50 mg/ml streptomycin. Protein expression was
performed in 500 ml suspension cultures of BTI-TN-5B1–4 insect
cells growing in Express Five SFM supplemented with 4 mM
glutamine, 50 U/ml penicillin, and 50 mg/ml streptomycin in
Fernbach flasks using a Multitron orbital shaker (INFORS AG,
Bottmingen, Switzerland). Cells were infected at a density of 2 106
cells/ml with an amplified viral stock at a MOI of B10. Protein
expression was stopped after 72 hours. Meprin a was further purified
from the media by ammonium sulfate precipitation (60% saturation),
stirring overnight at 41C, followed by centrifugation at 11,000 g for
2 hours at 41C. Pellets were dissolved in 1/10 volume of 100 mM Tris-
HCl, pH 8.0, 50 mM NaCl and dialyzed against the same buffer.
Afterwards the protein solution was loaded on a streptavidin column
(IBA, Go¨ttingen, Germany). After a washing step using 20 ml of
100 mM Tris-HCl, pH 8.0, 50 mM NaCl, protein was eluted with
100 mM Tris-HCl, pH 8.0, 50 mM NaCl, 2.5 mM D-desthiobiotin under
native conditions. Furthermore, protein was concentrated using
Amicon Ultra Centrifugal Filter Devices (Millipore, Schwalbach,
Germany). Activation was carried out as described before for meprin
b (Becker et al., 2003).
Immunofluorescence analysis
The used polyclonal antisera from rabbit were generated against the
following peptides: the a subunit-specific antibody is directed
against a fragment of 420 amino-acid residues including the
propeptide, the protease, and MAM domain of human meprin a.
The b-specific antibody was obtained using a peptide comprising
150 amino acid residues of the TRAF domain of the human b
subunit. The crossreactive antibodies detecting both subunits were
generated using a 330-residue-long peptide including the propep-
tide, the protease domain, and a part of the MAM domain of human
meprin b. All antigen peptides were expressed in Escherichia coli
(Dumermuth et al., 1993; Lottaz et al., 1999a).
Cryosections of normal (10 patients) and hyperkeratotic human
skins from four patients with N.s., five patients with P.v., and five
patients suffering from I.v., as well as monolayers of keratinocytes
(HaCaTs) and insect cells (HighFive) on cover glasses were
incubated with normal goat serum (Jackson ImmunoResearch via
Dianova, Hamburg, Germany), 10% in phosphate-buffered saline
(9.2 mM Na2HPO4, 1.8 mM KH2PO4, 135 mM NaCl, 2.7 mM KCl, pH
7.4), to block nonspecific binding. Then the samples were incubated
at 41C for 18 hours with anti-meprin sera or monoclonal anti-human
transglutaminase 1 antibody (Biomedical Technologies Inc., Stought-
en; 1:1,200 in phosphate-buffered saline). To perform epitope-
competition experiments, antibodies were incubated with respective
immunogens, namely recombinant human meprin a and b at room
temperature for 2 hours before sample incubation. Excess antibodies
were removed by washing with phosphate-buffered saline, and the
samples were again incubated at room temperature for 2 hours with
Alexa 568 (Invitrogen GmbH, Karlsruhe, Germany) or fluorescein
isothiocyanate-conjugated anti-rabbit or anti-mouse IgG (Jackson
ImmunoResearch via Dianova, Hamburg, Germany). For HaCaT
analyses, nuclei were stained with 4,6-diamidino-2-phenylindole
(Applichem GmbH, Darmstadt, Germany). Immunofluorescence
detection was carried out by an Axioskop 2 (Carl Zeiss AG, Jena,
Germany) or via a confocal laser scanning microscope (Leica TCS
NT; Leica Microsystems, Wetzlar, Germany).
Incubation of HaCaTs with recombinant meprins
The HaCaT cells were seeded in chambers of microscope slides (BD
FalconTM CultureSlides; BD Biosciences, Heidelberg, Germany).
After total confluence, recombinant meprins were added to the
cells at different concentrations (100, 500 ng, 1, 2, 5, and 10mg)
each in a threefold assay. As a control, HaCaTs incubated with
recombinant protein in the presence of actinonin (0.5 mM) or without
meprin were analyzed. After 18 hours incubation, the chambers
were removed and the keratinocytes were analyzed using an
Axioskop 2 (Carl Zeiss AG, Jena, Germany).
Cell proliferation assay and apoptosis detection kit
For assessing the proliferation after treatment with recombinant
meprins, HaCaT keratinocytes were seeded in serum-free medium
into chambers of BD FalconTM CultureSlides (BD Biosciences,
Heidelberg, Germany). After total confluent growth of the cells,
recombinant meprins were added at different concentrations (100,
500 ng, 1, 2, 5, and 10 mg) each in triplicate assays. As a control,
HaCaTs without meprin were analyzed. After 18 hours incubation,
MTT, a component of the VybrantsMTT Cell Proliferation Assay Kit,
was added to the keratinocytes and further treatment was performed
using the suppliers’ instruction (Invitrogen, Karlsruhe, Germany).
To visualize apoptosis after meprin treatment, HaCaT cells were
cultured and incubated with recombinant protein as described
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above. Apoptotic cells were detected using Annexin V-fluorescein
isothiocyanate Apoptosis Detection Kit II (Merck/Calbiochem,
Darmstadt, Germany). This assay has been designed especially for
whole cells and depends on the interaction between phosphatidyl-
serine and annexin V. The test was carried out following the
providers’ instruction.
Azocasein assay
To test whether human kallikrein-related peptidase 4 (KLK4) is able
to convert the zymogen form of meprin b to the mature enzyme, an
activity assay using azocasein as substrate was established.
Recombinant meprin b was incubated with 100 nM trypsin or
300 nM KLK4 at 371C for different periods of time. After preincuba-
tion, trypsin and KLK4 were inhibited by the addition of 5 mM
Pefabloc. Low remaining background activity was subtracted from
all samples. Although trypsin fully activated the b subunit within
30 minutes, incubation with KLK4 was not as efficient, but maximum
activity could be generated within 120 minutes. The addition of
0.1 mM actinonin completely inhibited azocasein degrading activity.
Recombinant KLK4 was cloned, expressed, and purified as described
elsewhere (Beaufort et al., 2006).
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